Cargando…
Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study
We evaluated 40 patients undergoing high-dose chemo/radiotherapy (HDCT) and hematopoietic stem cell transplantation (HSCT) (allogeneic (22), autologous (18)) to determine the safety and feasibility of administering low molecular weight heparin (LMWH) as hepatic veno-occlusive disease (VOD) prophylax...
Autores principales: | Forrest, D L, Thompson, K, Dorcas, V G, Couban, S H, Pierce, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091773/ https://www.ncbi.nlm.nih.gov/pubmed/12796794 http://dx.doi.org/10.1038/sj.bmt.1704087 |
Ejemplares similares
-
PB2472: HOSPITAL BURDEN OF VENO-OCCLUSIVE DISEASE (VOD): COMPARISON OF HOSPITAL STAYS WITH VOD PRINCIPAL VERSUS SECONDARY DIAGNOSIS
por: Aggarwal, Saurabh, et al.
Publicado: (2023) -
Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)
por: Richardson, Paul, et al.
Publicado: (2019) -
PB1875: NON-HEMATOPOIETIC CELL TRANSPLANT-RELATED VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) IN SOLID TUMOR AND HEMATOLOGIC MALIGNANCIES: A SYSTEMATIC REVIEW
por: Stewart, Fiona, et al.
Publicado: (2023) -
Publisher Correction: Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)
por: Richardson, Paul, et al.
Publicado: (2019) -
P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED ADULT PATIENTS FROM THE DEFIFRANCE STUDY
por: Mohty, M., et al.
Publicado: (2022)